INSIGHTS ON SOLID DOSE MANUFACTURING
-
Safely Scaling High Potency API Manufacturing
Scaling HPAPI production demands disciplined containment and exposure control. Integrated operating models help manage risk while enabling compliant, reliable scale‑up.
-
Lipid Formulation Development: Why Softgels Are The Technology Of Choice
Low bioavailability affects roughly 80% of APIs, yet many drug developers default to standard OSD forms. This paper examines why softgels deserve earlier consideration in formulation strategy.
-
Developing And Manufacturing Drugs With HPAPIs
Learn why companies must invest in specialized expertise to develop scalable, safe, and efficient manufacturing processes for highly potent oral solid dose products.
-
Benefits Of Isolator Technology In Fill-Finish
Isolator technology enhances sterility assurance, reduces contamination risk, improves operator safety, and supports regulatory compliance, making it essential for modern aseptic fill-finish operations.
-
Combining Powdose® And Diffucaps® For Precise Solid Oral Dosing6/30/2025
Combining POWDOSE® and Diffucaps® enables precise, individualized solid oral dosing—improving drug delivery, patient compliance, and therapeutic outcomes in personalized medicine applications.
-
Maximize Uptime And Yield With This Feeder Base Leveling System10/8/2025
Learn how a patented leveling system provides real-time, three-gauge feedback, ensuring precision, maximizing uptime, and protecting your critical production equipment.
-
Enabling Complex Phase IIa Dosing Through Flexible Clinical Packaging Design5/6/2026
Discover how flexible, patient‑centric clinical packaging supports complex Phase IIa dosing while protecting timelines, ensuring compliance, and avoiding costly primary packaging changes.
-
Advancing High Potency Manufacturing4/13/2026
Advance potent drug manufacturing through tighter containment, thoughtful process engineering, and closed handling that protects workers while improving efficiency and scale.
-
Ask Us Anything: Mark Benger On Solid-State Strategies For Drug Development7/23/2026
Mark Benger, Site Director at Cambrex Edinburgh, on solid-state characterization as an insurance policy — front-loaded work that quietly determines whether a program survives the jump from kilos to tonnes.
SOLID DOSE MANUFACTURING SOLUTIONS
-
The patented DCS® pharmaceutical Drum Containment System is a stainless steel cylindrical glove box with a glass cover and two glove ports. Highly economical in comparison with conventional isolation systems, DCS® ensures precise, contamination free emptying of drums providing high containment (< 1 µg/m3).
-
Solid form screening optimizes drug properties by evaluating polymorphs, salts, and cocrystals to improve solubility, stability, and manufacturability using advanced analytics.
-
A flexible, data‑driven development approach assembles tailored scientific strategies around each molecule, reducing risk, improving manufacturability, and enabling scalable formulation solutions.
-
Our rotary turret uses proven tablet-press -based, principles. It progressively compresses powder into small pockets on a continuously rotating disk using a combination of rotors and pins. The resultant doses are then transferred to blister strip as it passes underneath the disk.
-
Ropack Pharma Solution’s ample, nimble capacity and validated processes bring quality and reliability to encapsulation.